Experiment 481288

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationMOSCARELLA,S: GIUSTI,A: MARRA,F: MARENA,C: LAMPERTICO,M: RELLI,P: GENTILINI,P: BUZZELLI,G:. (1993). THERAPEUTIC AND ANTILIPOPEROXIDANT EFFECTS OF SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX IN CHRONIC LIVER DISEASE: PRELIMINARY RESULTS.. 53(1)
Amount utilized
Compound isolated
DiseaseDOSING TWICE DAILY FOR 2 MONTHS. ALL 8 PATIENTS SHOWED DECREASED ENZYME LEVELS(AST, ALT, GGT, ALP). SERUM MDA LEVELS MARKEDLY DECREASED. GEC LEVELS SLIGHTLY INCREASED. PATIENTS HAD CHRONIC VIRAL HEPATITIS. A NEW SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX WAS USED IN THE STUDY.
Dose amount120.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES